Unfortunately, those thymomas preferentially targetable by immune checkpoint inhibition due to a high PD-L1 expression and high counts of CD8+ lymphocytic infiltrates are often associated with myasthenia gravis [21]. The gene discussed is CD274; the disease is thymoma.